However, when stratified by breast cancer subtype, we found a trend towards improved OS (HR = 0.51; 95% CI 0.25–1.03) in the Black triple-negative breast cancer patients with high CD8+ T cell density compared to those with low CD8+ density (Fig. 2a). This evidence concerns the gene CD8A and breast cancer.